Trial · NCT07588932
Relying on Pharmacotherapy to Improve Motor Gains in Chronic Stroke Survivors
NCT07588932, Early phase 1, Recruiting, Spaulding Rehabilitation Hospital
3 sourcestrials-2026-11-12-0.4.0
Cite this record
ConductScience Library. Relying on Pharmacotherapy to Improve Motor Gains in Chronic Stroke Survivors. Trials, record NCT07588932. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07588932
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Relying on Pharmacotherapy to Improve Motor Gains in Chronic Stroke Survivors
- NCT number
- NCT07588932
- Status
- Recruiting
- Phases
- Early phase 1
- Enrollment
- 50 participants, estimated
- Lead sponsor
- Spaulding Rehabilitation Hospital
- Conditions
- Stroke
- Interventions
- Telmisartan, Metformin, Cilostazol
- First posted
- 2026-05-15
- Last updated
- 2026-07-14
Source ClinicalTrials.gov
Registered outcomes4
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Fugl-Meyer Assessment - Upper Extremity (FMA-UE) | Will be assessed at baseline, at 8 weeks, and at the end of the 12-week study | The FMA-UE is a widely used, standardized test that measures movement, coordination, and reflexes of the arm, wrist, and hand after a stroke. Scores reflect the degree of motor impairment, with higher scores indicating better motor function (range 0-66). |
| Secondary | Action Research Arm Test (ARAT) | Will be assessed at baseline, at 8 weeks, and at the end of the 12-week study. | The ARAT is a standardized test of upper limb function after stroke. It assesses the ability to grasp, grip, pinch, and move objects, with higher scores indicating better arm and hand function (range 0 to 57). |
| Secondary | Stroke Impact Scale (SIS) | Will be completed at baseline, at 8 weeks, and at the end of the 12-week study. | The SIS is a self-reported questionnaire that measures how stroke has affected daily activities, mobility, communication, emotion, memory, and quality of life. Higher scores reflect better function and well-being (range 0 to 100) |
| Secondary | Mini Mental State Exam (MMSE scale) | Will be completed at baseline, at 8 weeks, and at the end of the 12-week study. | An 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language (range 0 to 30). |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers40
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07588932
GET https://conductscience.org/api/trials/v1/NCT07588932/papers?page=2